Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

statin

statin is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 116
News articles 0
Drug details — statin
Class
—
Route
—
Patents
20
Programs
116
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

statin is an FDA-listed pharmaceutical active ingredient.

Key facts

INN statin

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Amlodipine/atorvastatin single pill Phase 3 · Pfizer · Hypertension
  2. Atorvastatin Phase 3 · Amgen · Hyperlipidemia
  3. Atorvastatin Phase 3 · Regeneron UK · Hypercholesterolemia
  4. CAAA601A22301 Phase 3 · Advanced Accelerator Applications · Patients with somatostatin receptor positive, well-different
  5. CAAA601A62301 Phase 3 · Novartis India · Gastroenteropancreatic neuroendocrine tumor (GEP-NET)
  6. CKJX839A12309 Phase 3 · Novartis India · Acute coronary syndrome (ST-elevation myocardial infarction
  7. CKJX839B12302 Phase 3 · Novartis India · Atherosclerotic cardiovascular disease (ASCVD)
  8. CKJX839D12303 Phase 3 · Novartis India · Non-obstructive Coronary Artery Disease

Related patents

Browse patents

  1. US 12258370

    Betulastatin compounds

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12122837

    Oncostatin M receptor antigen binding proteins

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12053511

    Cystatin C and Cystatin 9 to treat gut inflammation caused by thermal injury

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11890290

    Topical treatment of wounds with statins and cholesterol for scar reduction

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11725043

    Ulinastatin polypeptides

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11661441

    Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11629167

    Betulastatin compounds

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11548889

    Emetine auristatin compounds

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11407789

    Cell-penetrating compstatin analogs and uses thereof

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11174291

    Silstatin compounds

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11065262

    Topical treatment of wounds with statins and cholesterol for scar reduction

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11015200

    Antisense-induced exon exclusion in myostatin

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11001610

    Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10941184

    Cell-penetrating compstatin analogs and uses thereof

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10933081

    Myostatin iRNA compositions and methods of use thereof

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10696718

    Compstatin analogs for treatment of neuropathic pain

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10596259

    Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10435435

    Quinstatin compounds

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10421813

    Oncostatin M receptor antigen binding proteins

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10407466

    Methods of selecting compstatin mimetics

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is statin?

statin is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.